![<p data-pm-slice="1 1 []" >Molecular illustration of CRISPR editing the DNA double helix</p>](https://cdn.the-scientist.com/assets\articleNo\71808\hImg\52947\68135-ts-ppl-poster-cellecta-banners-jd-1800-x-720-x.webp "<p data-pm-slice=\"1 1 []\" >Molecular illustration of CRISPR editing the DNA double helix</p>")
Scientists engineer CRISPR technologies that use Cas proteins and guide RNAs to target genes for in vitro and in vivo genome editing. Cas9-mediated tools are the foundation of CRISPR technologies, setting the stage for new generation base editors and prime editors, and opening the door to genome editing therapeutics with greater precision.
Download this poster from The Scientist to learn about the advent of base editing and prime editing approaches and applications.
Top Image Credit:
A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.
View this Issue
In this webinar, Ethan Shelkey and Aurita Menezes will highlight key aspects in the design of cell-based assays.
Discover how alternative animal models provide new perspectives on physiological and biochemical processes.
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
Learn how to overcome the challenges of viral transduction workflows.
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug discovery and disease research with unprecedented scalability, reproducibility, and efficiency.
Learn how a target enrichment approach improves the discovery and characterization of viral pathogens.
